<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:02:24Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5037613" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5037613</identifier><datestamp>2016-10-05</datestamp><setSpec>genbio</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Genome Biol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Genome Biol</journal-id>
      <journal-title-group>
        <journal-title>Genome Biology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1474-7596</issn>
      <issn pub-type="epub">1474-760X</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5037613</article-id>
      <article-id pub-id-type="pmcid">PMC5037613</article-id>
      <article-id pub-id-type="pmc-uid">5037613</article-id>
      <article-id pub-id-type="pmid">27677260</article-id>
      <article-id pub-id-type="publisher-id">1061</article-id>
      <article-id pub-id-type="doi">10.1186/s13059-016-1061-6</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>GNB5 mutation causes a novel neuropsychiatric disorder featuring attention deficit hyperactivity disorder, severely impaired language development and normal cognition</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Shamseldin</surname>
            <given-names>Hanan E.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Masuho</surname>
            <given-names>Ikuo</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alenizi</surname>
            <given-names>Ahmed</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alyamani</surname>
            <given-names>Suad</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Patil</surname>
            <given-names>Dipak N.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ibrahim</surname>
            <given-names>Niema</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Martemyanov</surname>
            <given-names>Kirill A.</given-names>
          </name>
          <address>
            <phone>+1-561-228-2770</phone>
            <email>Kirill@scripps.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Alkuraya</surname>
            <given-names>Fowzan S.</given-names>
          </name>
          <address>
            <phone>+966114427875</phone>
            <email>falkuraya@kfshrc.edu.sa</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Genetics, King Faisal Specialist Hospital and Research Center, MBC-03, PO Box 3354, Riyadh, 11211 Saudi Arabia </aff>
        <aff id="Aff2"><label>2</label>Department of Neuroscience, The Scripps Research Institute, 130 Scripps Way, #3C2, Jupiter, FL 33458 USA </aff>
        <aff id="Aff3"><label>3</label>Department of Pediatrics, King Saud Medical City, Riyadh, Saudi Arabia </aff>
        <aff id="Aff4"><label>4</label>Department of Neurosciences, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia </aff>
        <aff id="Aff5"><label>5</label>Department of Anatomy and Cell Biology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>9</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>27</day>
        <month>9</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>17</volume>
      <elocation-id>195</elocation-id>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>7</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>9</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© The Author(s). 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Neuropsychiatric disorders are common forms of disability in humans. Despite recent progress in deciphering the genetics of these disorders, their phenotypic complexity continues to be a major challenge. Mendelian neuropsychiatric disorders are rare but their study has the potential to unravel novel mechanisms that are relevant to their complex counterparts.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>In an extended consanguineous family, we identified a novel neuropsychiatric phenotype characterized by severe speech impairment, variable expressivity of attention deficit hyperactivity disorder (ADHD), and motor delay. We identified the disease locus through linkage analysis on 15q21.2, and exome sequencing revealed a novel missense variant in <italic>GNB5. GNB5</italic> encodes an atypical Î² subunit of the heterotrimeric GTP-binding proteins (GÎ²5). GÎ²5 is enriched in the central nervous system where it forms constitutive complexes with members of the regulator of G protein signaling family of proteins to modulate neurotransmitter signaling that affects a number of neurobehavioral outcomes. Here, we show that the S81L mutant form of GÎ²5 has significantly impaired activity in terminating responses that are elicited by dopamine.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>We demonstrate that these deficits originate from the impaired expression of the mutant GÎ²5 protein, resulting in the decreased ability to stabilize regulator of G protein signaling complexes. Our data suggest that this novel neuropsychiatric phenotype is the human equivalent of <italic>Gnb5</italic> deficiency in mice, which manifest motor deficits and hyperactivity, and highlight a critical role of GÎ²5 in normal behavior as well as language and motor development in humans.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s13059-016-1061-6) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Linkage</kwd>
        <kwd>Mendelian</kwd>
        <kwd>Neuropsychiatric disorders</kwd>
        <kwd>Attention deficit hyperactivity disorder (ADHD)</kwd>
        <kwd>G protein coupled receptors (GPCR)</kwd>
        <kwd>Hippocampus</kwd>
        <kwd>Striatum</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004919</institution-id>
              <institution>King Abdulaziz City for Science and Technology</institution>
            </institution-wrap>
          </funding-source>
          <award-id>13-BIO1113-20</award-id>
          <principal-award-recipient>
            <name>
              <surname>Alkuraya</surname>
              <given-names>Fowzan S.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>Â© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>It is increasingly recognized that neuropsychiatric disorders have complex etiology and that many conditions defy classical definitions based purely on phenotypic observations [<xref ref-type="bibr" rid="CR1">1</xref>]. While there has been tremendous progress towards understanding the genetic basis of hereditary neuropsychiatric conditions, linking specific pathological states to exact molecular alterations has been challenging [<xref ref-type="bibr" rid="CR2">2</xref>].</p>
      <p>One large group of genes with prominent roles in neuropsychiatric disease process encodes components of neurotransmitter signaling cascades acting via G protein coupled receptors (GPCR) [<xref ref-type="bibr" rid="CR3">3</xref>]. Notably, pharmacological modulation of signaling efficacy at GPCR has been among the most successful strategies for controlling the symptoms of several mental conditions [<xref ref-type="bibr" rid="CR4">4</xref>]. In the context of neurodevelopmental disorders manifesting in hyperactivity, this frequently includes modulation of signaling via receptors for neurotransmitter dopamine [<xref ref-type="bibr" rid="CR5">5</xref>]. GPCRs transmit their signals by activating heterotrimeric guanine nucleotide-binding proteins (G proteins). In the basal state, the GDP-bound GÎ± subunit is tightly bound to the GÎ²Î³ heterodimer. Upon successful binding of GPCRs to their ligands, GDP is exchanged for GTP and the heterodimer dissociates such that each of its components can initiate a series of signaling cascades that mediate the net biological effect of the ligand [<xref ref-type="bibr" rid="CR6">6</xref>].</p>
      <p>The strength of the signaling in GPCR cascades is controlled by the members of the regulator of G protein signaling (RGS) proteins, which terminate the signaling initiated by the GPCRs by accelerating the GTP hydrolysis on the GÎ± subunits, thereby promoting their inactivation. RGS proteins also act as signaling thresholders preventing constitutive and uncontrolled G protein signaling in the absence of GPCR activation [<xref ref-type="bibr" rid="CR7">7</xref>â<xref ref-type="bibr" rid="CR11">11</xref>]. In the nervous system, the critical role in controlling GPCR signaling belongs to members of the R7 subfamily of RGS proteins that includes RGS6, RGS7, RGS9, and RGS11. Collectively, R7 RGS proteins have been implicated in learning, motor control, and vision by controlling several neurotransmitter systems including dopamine, opioid, glutamate, and GABA [<xref ref-type="bibr" rid="CR12">12</xref>]. However, with an exception of the established role of RGS9 in retina pathology [<xref ref-type="bibr" rid="CR13">13</xref>] and ample evidence from mouse models [<xref ref-type="bibr" rid="CR14">14</xref>], contributions of R7 RGS proteins to inherited neuropsychiatric conditions in humans has not been documented, despite their strategic role in controlling key relevant processes.</p>
      <p>A hallmark of R7 RGS protein organization is their association with GÎ²5, a divergent member of the GÎ² family through their GÎ³-like (GGL) domains [<xref ref-type="bibr" rid="CR15">15</xref>â<xref ref-type="bibr" rid="CR17">17</xref>]. GÎ²5 is encoded by <italic>GNB5</italic> and shares only ~50Â % sequence similarity with classical GÎ²1â4 subunits that transmit GPCR signals and are ~90Â % identical to each other. GÎ²5 also appears to be the only member of GÎ² family that can have cellular localization other than the cell membrane, e.g. cytosolic and nuclear [<xref ref-type="bibr" rid="CR18">18</xref>]. All R7 RGS proteins in vivo exist in complexes with GÎ²5, and GÎ²5 together with its R7 RGS partners depend on each other for stability; in addition, the GTPase activating protein (GAP) activity of R7 RGS proteins is enhanced several folds when co-expressed with GÎ²5 [<xref ref-type="bibr" rid="CR19">19</xref>â<xref ref-type="bibr" rid="CR24">24</xref>].</p>
      <p>Several lines of evidence support an important neurobiological role of GÎ²5. Expression analysis revealed strong enrichment in the brain, particularly in the hippocampus and striatum [<xref ref-type="bibr" rid="CR25">25</xref>]. More importantly, <italic>Gnb5</italic> knockout mice display a multitude of neurobehavioral abnormalities [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Unless assisted for feeding, these mice die shortly after birth. Motor delay persists in the early postnatal developmental period and these mice later develop marked hyperactivity. Interestingly, hyperactivity seen in <italic>Gnb5</italic> deficient mice is paralleled by a number of molecular abnormalities including higher sensitivity of inhibitory GPCR signaling and deficits in basal levels, release, and reuptake of dopamine [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Since these disturbed processes have been implicated in the pathogenesis of ADHD in humans, it was suggested that <italic>Gnb5</italic><sup>â/â</sup> is a good animal model for this disease [<xref ref-type="bibr" rid="CR28">28</xref>].</p>
      <p>The highly consanguineous nature of the Saudi population provides an ideal setting for the discovery of recessive mutations that are too rare to exist biallelically in outbred populations [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. We have previously shown this can greatly accelerate the discovery of novel genes for various neurodevelopmental disorders [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. In this study, we show that an extended consanguineous family reveals the long sought <italic>GNB5</italic>-related phenotype in humans: a neuropsychiatric disorder characterized by severe impairment in acquisition of speech, hyperactivity, attention deficits, and motor delay.</p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec3">
        <title>Human participants</title>
        <p>All affected family members were evaluated by a certified pediatric neurologist. The diagnosis of ADHD was based on established DSM IV criteria. Intelligence was evaluated using the Wechsler Intelligence Scale for Children (WISC) whenever possible. Affected and available unaffected family members were recruited after signing a written informed consent form as part of an IRB-approved research protocol (KFSHRC RAC#2121053). Venous blood was collected in EDTA and sodium heparin tubes for DNA extraction and the establishment of lymphoblastoid cell lines, respectively. All experimental methods comply with the Helsinki Declaration.</p>
      </sec>
      <sec id="Sec4">
        <title>Autozygosity mapping and linkage analysis</title>
        <p>Genome-wide single nucleotide polymorphism (SNP) genotyping was carried out using Axiom SNP Chip Array, which has &gt;500,000 SNPs, following the manufacturerâs instructions (Affymetrix). Determination of the entire set of autozygous intervals per genome (autozygome) used AutoSNPa. We used regions of homozygosity (ROH) &gt;2Â Mb in size as surrogates of autozygosity [<xref ref-type="bibr" rid="CR34">34</xref>]. We then searched for the critical autozygous interval that harbors the disease-causing mutation by comparing the autozygome of affected and unaffected members to identify autozygous intervals that are exclusively shared by the affected members as described before [<xref ref-type="bibr" rid="CR35">35</xref>]. Linkage analysis was performed using the EasyLINKAGE software. We used a fully penetrant autosomal recessive disease model and assumed homozygosity for the disease-causing mutation based on a shared ancestor.</p>
      </sec>
      <sec id="Sec5">
        <title>Exome sequencing</title>
        <p>Exome capture was performed using TruSeq Exome Enrichment kit (Illumina) following the manufacturerâs protocol. Samples were prepared as an Illumina sequencing library, and in the second step, the sequencing libraries were enriched for the desired target using the Illumina Exome Enrichment protocol. The captured libraries were sequenced using an Illumina HiSeq 2500 Sequencer to an average read depth of target regions of 81.8X. The reads were mapped against UCSC hg19 by BWA. The SNVs and indels were detected by SAMTOOLS. WES data were filtered by only considering homozygous variants within the critical autozygous interval, with a MAF &lt;0.001 (as determined by ExAC and 2379 in-house Saudi exomes) [<xref ref-type="bibr" rid="CR36">36</xref>]. We assessed potential pathogenicity of missense variants based on PolyPhen, SIFT, and CADD.</p>
      </sec>
      <sec id="Sec6">
        <title>Complementary DNA constructs</title>
        <p>Plasmid encoding the Flag-tagged, long isoform of the D2 dopamine receptor was a gift from A. Kovoor (University of Rhode Island). pCMV5 plasmids encoding GÎ±oA were gifts from H. Itoh (Nara Institute of Science and Technology, Japan). Plasmids encoding Venus 156-239-GÎ²1 and Venus 1-155-GÎ³2 were gifts from N. Lambert (Georgia Regents University) [<xref ref-type="bibr" rid="CR37">37</xref>]. Plasmids encoding RGS9-2, GÎ²5, R7BP, and masGRK3ct-Nluc were previously described [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. Of the two known splice isoforms, we chose to study GÎ²5S (NM_006578) for its ubiquitous expression in the nervous system and the lack of the other isoform, GÎ²5L, in the brain.</p>
      </sec>
      <sec id="Sec7">
        <title>Real-time monitoring of G protein signaling by fast kinetic bioluminescence resonance energy transfer assay</title>
        <p>Agonist-dependent cellular measurements of bioluminescence resonance energy transfer (BRET) between masGRK3ct-Nluc and Venus-tagged GÎ²Î³ were performed to visualize the action of G protein signaling in living cells as previously described with slight modifications [<xref ref-type="bibr" rid="CR39">39</xref>]. HEK293T/17 was transfected with Lipofectamine LTX (12Â Î¼L per dish) and PLUS (7.5Â Î¼L per 6-cm dish) reagents. Dopamine D2 receptor, GÎ±oA, Venus-156-239-GÎ²1, Venus-1-155-GÎ³2, masGRK3ct-Nluc, RGS9-2, GÎ²5, and R7BP constructs (total 7.5Â Î¼g) were used at a 1:2:1:1:1:1:0.5:0.5:0.5 ratio (ratio 1â=â0.42Â Î¼g of plasmid DNA). BRET measurements were made with a microplate reader (POLARstar Omega; BMG Labtech) equipped with two emission photomultiplier tubes, allowing us to detect two emissions simultaneously with resolution of 20Â ms for every data point. All measurements were performed at room temperature. The BRET signal is determined by calculating the ration of the light emitted by the Venus-GÎ²1Î³2 (535Â nm with a 30-nm band path width) over the light emitted by the masGRK3ct-Nluc (475Â nm with a 30-nm band path width). The average baseline value recorded before agonist stimulation was subtracted from BRET signal values and the resulting difference (ÎBRET ratio) was plotted as traces. The rate constant (1/Ï) of deactivation phase were obtained by fitting a single exponential function to the traces with Clampfit ver. 10.3 software (Molecular Devices). <italic>k</italic><sub>GAP</sub> rate constants were determined by subtracting the basal deactivation rate constant (<italic>k</italic><sub>app</sub>) from the deactivation rate constant measured in the presence of exogenous RGS9-2/GÎ²5 dimer or RGS9-2/GÎ²5/R7BP trimer. Obtained <italic>k</italic><sub>GAP</sub> rate constants were used to quantify GAP activity of RGS9-2 complexes.</p>
      </sec>
      <sec id="Sec8">
        <title>Immunoblotting</title>
        <p>Western blot was carried out to check for the stability of GNB5 protein in patient lymphoblasts compared to control lymphoblasts, using Anti-GNB5(ab185214-Abcam). Briefly, protein was extracted using RIPA buffer (SIGMA) and Halt protease inhibitor cocktail (Thermo-Fisher Scientific), followed by centrifugation at 14,000â<italic>g</italic> at 4Â Â°C for 15Â min. Protein obtained in the supernatants was separated by electrophoresis on 4â12Â % gradient Trisâglycine gels (Invitrogen) and transferred onto polyvinylidene difluoride membrane (Invitrogen), followed by blocking in 1Ã PBS with 5Â % casein and 0.1Â % Tween-20, incubation with primary antibody, and finally incubation with horseradish peroxidase-conjugated IGg secondary antibody. SuperSignal chemiluminescent substrate kit (Pierce) was applied to detect the level of protein expression. Reduction in the protein level was quantified using ImageJ and compared across three independent immunoblots. Immunoblotting of transfected cells were performed as previously reported [<xref ref-type="bibr" rid="CR22">22</xref>]. To ensure pseudo-linearity of the signal several film exposures were evaluated and non-saturating blots were chosen for the analysis.</p>
      </sec>
    </sec>
    <sec id="Sec9" sec-type="results">
      <title>Results</title>
      <sec id="Sec10">
        <title>Identification of a novel autosomal recessive neuropsychiatric disorder</title>
        <p>Through our ongoing effort to identify Mendelian forms of neuropsychiatric disorders in children, we encountered an extended consanguineous Saudi family with multiple members who share the core feature of severe expressive language delay (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). The five affected members represent three different sibships (Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>). In the first sibship, the index (V:1) is a 10-year-old girl who presented to pediatric neurology with severe expressive and receptive language delay, marked hyperactivity, and school performance issues despite having a normal IQ. She was diagnosed with ADHD according to the DSM IV criteria. Her younger 9-year-old sister (V:2) also had severe expressive and receptive language delay, and although she had no hyperactivity, she met the DSM IV criteria for inattentive type ADHD. Like her sister, she had normal cognitive development. The youngest 3-year-old sister (V:3) was too young to assess for ADHD but, like her other two sisters, had severe language delay. Their first cousin is a 5-year-old girl (IV:1) who initially presented with motor delay and hypotonia but was later found to have severely delayed language development but normal IQ. A distant cousin (IV:6, 9Â years old) was not available for formal evaluation but available reports from a different institution showed ADHD diagnosis, severely delayed language acquisition, and mild motor delay.<fig id="Fig1"><label>Fig. 1</label><caption><p>A novel neuropsychiatric disorder is linked to <italic>GNB5</italic> mutation. <bold>a</bold> Pedigree of the study family. <bold>b</bold>
<italic>Ideogram</italic> showing a single autozygous interval on chr15 (47,051,884-57,799,765, demarcated by SNPs rs11854077 and rs1280355) that is exclusively shared by the affected members. <bold>c</bold> Genome-wide linkage analysis shows a single linkage peak on chr15 with LOD ~4 that corresponds to the single autozygous interval shown in (<bold>b</bold>). A <italic>screenshot</italic> from the UCSC Genome Browser is shown to highlight the gene content of the linkage peak (<italic>GNB5</italic> is boxed in <italic>red</italic>). <bold>d</bold>
<italic>Schematic</italic> of <italic>GNB5</italic> (transcript NM_ 006578) with the sequence chromatogram of the mutation shown on <italic>top</italic>. <bold>e</bold>
<italic>Schematic</italic> of GÎ²5 and the location of the missense mutation indicated. <bold>f</bold> Strong cross-species conservation of the Ser81 residue denoted with a <italic>red asterisk</italic> (<italic>black asterisks</italic> in the <italic>bottom</italic> denote highly conserved residues)</p></caption><graphic xlink:href="13059_2016_1061_Fig1_HTML" id="MO1"/></fig></p>
      </sec>
      <sec id="Sec11">
        <title>A novel neuropsychiatric syndrome is linked to a novel variant in <italic>GNB5</italic></title>
        <p>The pedigree structure was highly suggestive of an autosomal recessive inheritance (the apparent female predominance was likely reflective of the mostly female offspring in the three nuclear families). Therefore, we proceeded with autozygome analysis and identified a single autozygous interval that was exclusively shared by the five affected members IV:1, IV:6, V:1, V:2, and V:3 (Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>). Under the hypothesis that the phenotype observed in this family is caused by homozygosity for a pathogenic mutation within an ancestral haplotype, we proceeded with linkage analysis and the result was fully concordant with autozygosity mapping in that the same critical interval was identified and a significant LOD score of ~4 was obtained (Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>). We then exome sequenced the index and despite full coverage (&gt;10 reads) of all exons of 104 genes in the critical interval, only one novel homozygous variant was identified therein: <italic>GNB5</italic>: NM_006578.3:c.242Câ&gt;âT:p.(S81L). This variant is absent in 2379 Saudi exomes and in the 1000 Genomes, and is present at a very low frequency in ExAC (6 out of 121,000 alleles with MAF of 4.959e-05, 0 homozygotes). It fully segregated with the syndrome in the family such that all affected members were homozygous, parents were heterozygous, while unaffected siblings were either heterozygous or homozygous for the normal allele (Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>). The identified amino acid substitution maps to the first WD40 repeat of the seven-propeller GÎ²5 fold within highly conserved region unique to this repeat (Fig.Â <xref rid="Fig1" ref-type="fig">1d</xref>).</p>
      </sec>
      <sec id="Sec12">
        <title>S81L GÎ²5 has reduced capacity to deactivate G protein signaling initiated by dopamine receptors</title>
        <p>Given the central role of dopamine in a variety of neuropsychiatric conditions and documented role of R7 RGS-GÎ²5 complexes in controlling signaling by the D2 dopamine receptors (D2R) [<xref ref-type="bibr" rid="CR28">28</xref>], we have next evaluated the functional impact of S81L mutation in GÎ²5 on termination of D2R responses, using a representative member of the R7 family, RGS9-2. We used optical means to record activation and deactivation of G protein Go by D2R in living cells by monitoring changes in BRET signal caused by dissociation of Go heterotrimer (Fig.Â <xref rid="Fig2" ref-type="fig">2a</xref>). In this assay, the addition of dopamine resulted in a rapid increase in BRET signal, which returns to the baseline upon the addition of the antagonist haloperidol (Fig.Â <xref rid="Fig2" ref-type="fig">2b</xref>). The speed of this termination phase is accelerated by RGS9, which in turn depends on GÎ²5 for its activity (Fig.Â <xref rid="Fig2" ref-type="fig">2c</xref>). Thus, the functional activity of GÎ²5 was determined by its ability to speed up D2R deactivation upon the addition of haloperidol in the presence of RGS9-2. Indeed, expressing wild-type GÎ²5 substantially accelerated response termination (Fig.Â <xref rid="Fig2" ref-type="fig">2c</xref>, <italic>green</italic> versus <italic>blue</italic> traces in the <italic>left</italic> graph). In contrast, the response offset kinetics was substantially slower in the presence of S81L (Fig.Â <xref rid="Fig2" ref-type="fig">2c</xref>, <italic>blue</italic> versus <italic>red</italic> traces in the <italic>left</italic> graph). Calculating the catalytic efficiency of the reaction by single exponential analysis revealed significantly weaker activity of RGS complexes containing mutant GÎ²5 (Fig.Â <xref rid="Fig2" ref-type="fig">2d</xref>). In addition to GÎ²5, R7 RGS complexes in vivo contain membrane anchoring subunit R7BP, which further augments their catalytic activity and requires GÎ²5for function [<xref ref-type="bibr" rid="CR38">38</xref>]. Therefore, we next determined the effect of GÎ²5 mutation in the presence of R7BP. Again, the addition of WT GÎ²5 dramatically facilitated the activity of RGS9-2, but this effect was very modest when S81L GÎ²5 was used instead. Therefore, we conclude that S81L results in severe but incomplete loss of function, detrimentally affecting the ability of R7 RGS proteins to deactivate D2R-mediated signaling.<fig id="Fig2"><label>Fig. 2</label><caption><p>Effect of S81L mutation on GAP activity of RGS9-2 complex. <bold>a</bold>
<italic>Schematic</italic> of the assay design. Stimulation of dopamine D2 receptor (D2R) by dopamine results in the dissociation of GÎ±oA from the heterotrimer. Released Venus-tagged GÎ²Î³ subunits become available for interaction with Nluc-tagged GRK3ct reporter, producing the BRET signal, which is determined by the change in the emission ratio at 535Â nm and 480Â nm. RGS9-2/GÎ²5 complexes exert GTPase Activating Protein (GAP) activity and accelerate deactivation of G proteins. <bold>b</bold> Representative BRET response of cells reconstituted D2R-GoA signaling. Responses to sequential application of dopamine (100Â Î¼M) and haloperidol (100Â Î¼M) were recorded. Data are means of six replicates. <bold>c</bold>
<italic>Trace lines</italic> represent the deactivation phase of D2R-GoA signaling after haloperidol application to cells transfected with different condition (<italic>left</italic> without R7BP and <italic>right</italic> with R7BP). Data are means of six replicates. <bold>d</bold>
<italic>k</italic>
<sub>GAP</sub> rate constants were calculated as an enzymatic activity of RGS9-2 complexes (for further details, see âMethodsâ) and plotted as a <italic>bar graph</italic>. The same color code was used in panel <bold>c</bold> and <bold>d</bold>. A single <italic>asterisk</italic> (*) indicates <italic>P</italic> &lt;0.0001. One-way ANOVA followed by Dunettâs post-hoc test was conducted with GraphPad Prism Ver. 6. Results shown are representative of two independent experiments each performed with six replicates. Values represent meansâÂ±âSEM</p></caption><graphic xlink:href="13059_2016_1061_Fig2_HTML" id="MO2"/></fig></p>
      </sec>
      <sec id="Sec13">
        <title>S81L mutation compromises GÎ²5 stability and reduces its ability to augment RGS expression</title>
        <p>We next sought to determine the mechanisms by which S81L mutation affects GÎ²5 function. In silico prediction suggests that the S81L variant likely has deleterious structural effects with three algorithms concurring on very high pathogenicity scores (1.0 on PolyPhen, 0.0 on SIFT, and 34 on CADD). To obtain structural insights into the impact of the S81L mutation on GÎ²5 at the atomic level, we modeled the consequences of this substitution using crystal structure of RGS9-GÎ²5 complex (Fig.Â <xref rid="Fig3" ref-type="fig">3a</xref>, <xref rid="Fig3" ref-type="fig">b</xref>) [<xref ref-type="bibr" rid="CR40">40</xref>]. S81 is buried inside the Î²-strand S2Î²2 of WD1 repeat close to central axis of Î²-propeller fold. The S81 is involved in side-chainâmain-chain type of hydrogen bond with V108 (Fig.Â <xref rid="Fig3" ref-type="fig">3c</xref>) and such interactions are known to be crucial for maintaining stable structure of the protein [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. Our modeling suggests that substituting Ser81 with hydrophobic leucine would abolish hydrogen bond formation with V108 and bulkier side chain of leucine at this position would not fit into the tightly packed antiparallel Î²-sheet of WD1 repeat resulting in a steric clash with neighboring residues (V87 on WD1; V108, C111, and C122 on WD2 (Fig.Â <xref rid="Fig3" ref-type="fig">3c</xref>). Thus, S81L substitution is predicted to compromise GÎ²5 folding and/or stability. To test these predictions, we analyzed the expression of GÎ²5 in patient-derived lymphoblasts by immunoblotting. Indeed, we detected a modest but consistent reduction of GÎ²5 protein levels in the two available lymphoblastoid lines derived from affected patients compared to healthy controls (Fig.Â <xref rid="Fig3" ref-type="fig">3d</xref>, <xref rid="Fig3" ref-type="fig">e</xref>). In order to rule out the possibility that the apparent reduction in GNB5 protein may have originated at the transcript level, qRT-PCR using patient and control RNA revealed equivalent levels of <italic>GNB5</italic> transcripts (Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><p>Effect of S81L mutation on protein expression of GÎ²5 and RGS9-2 complex. <bold>a</bold>
<italic>Cartoon representation</italic> of RGS9-GÎ²5 complex crystal structure (PDB ID:2PBI) with S81L mutation shown in the <italic>red sphere</italic>. RGS9 and GÎ²5 are shown in <italic>gray</italic> and <italic>cyan</italic>, respectively. <bold>b</bold>
<italic>Cartoon representation</italic> of GÎ²5 alone (PDB ID:2PBI) with S81 mutation shown in the <italic>red sphere</italic>. Residue S81 is present on Î²-strand S2Î²2 of WD1 repeat. WD1 and the neighboring WD2 repeats are represented in <italic>blue</italic> and <italic>orange</italic>, respectively. <bold>c</bold> The hydrogen bond formation of side chain of S81 (<italic>red</italic>) with backbone of V108 (<italic>orange</italic>) is shown as a <italic>dotted black line</italic>. The substituted residue L81 (<italic>green stick</italic>) will not be able to form a hydrogen bond; instead its bulkier side chain will have steric clashes with neighboring amino acids (V87, V108, C111, and C122 represented in stick). All structural representations are made using PyMOL software <ext-link ext-link-type="uri" xlink:href="https://www.pymol.org">https://www.pymol.org</ext-link>. <bold>d</bold> Summary of three qRT-PCR experiments (each performed in triplicates) using patient and control LCL to determine the relative abundance of <italic>GNB5</italic> in patient vs. controls showing no significant difference (two-tailed <italic>t</italic>-test p value 0.67). <bold>e</bold>, <bold>f</bold>
<italic>Western blot analysis</italic> of GNB5 expression in patient lymphoblastoid cells compared to normal control. <bold>g</bold>
<italic>Immunoblot analysis</italic> of protein expression in HEK293T/17 cells. RGS9-2, GÎ²5, and R7BP were expressed in different combinations. The proteins extracted from the transfected cells used in BRET assay were subjected to immunoblot analysis using the indicated specific antibodies. Anti-GAPDH antibody was used as a loading control. Representative experiment out of three independent evaluations is shown</p></caption><graphic xlink:href="13059_2016_1061_Fig3_HTML" id="MO3"/></fig></p>
        <p>To further characterize the effects of the mutation on the expression of GÎ²5, we heterologously expressed GÎ²5 constructs in HEK293T cells and determined its levels by immunoblotting. Similar to results with lymphoblastoid cells, we observed that S81L GÎ²5 mutant had lower expression levels relative to wild-type protein (Fig.Â <xref rid="Fig3" ref-type="fig">3f</xref>). Furthermore, S81L GÎ²5 had a reduced capacity to augment the expression of RGS9-2 both in the absence or presence of R7BP, suggesting detrimental effect of the mutation on the folding or stability of the R7 RGS complexes.</p>
      </sec>
    </sec>
    <sec id="Sec14" sec-type="discussion">
      <title>Discussion</title>
      <p>The family we present in this study provides a unique opportunity to observe the phenotypic consequence of GÎ²5 deficiency in humans. GNB5 knockdown in <italic>C. elegans</italic> results in increased locomotor activity [<xref ref-type="bibr" rid="CR43">43</xref>]. Knockout of the murine orthologue results in severe hyperactivity and abnormal motor coordination, findings that made us suggest that <italic>GNB5</italic> is a candidate gene for ADHD in humans [<xref ref-type="bibr" rid="CR28">28</xref>]. ADHD is an extremely common psychiatric disorder that affects 5Â % of school-age children, although some surveys estimate the prevalence to be &gt;11Â % [<xref ref-type="bibr" rid="CR44">44</xref>]. Despite its high prevalence and strong heritability, very little is known about its genetics. Like most other complex disorders, information on the genetics of ADHD comes from linkage analysis of families with strong familial aggregation, candidate gene case-control as well as genome-wide association studies (GWAS) [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. Interestingly, Mendelian forms, which have been identified for many other complex disorders, have not been reported for ADHD to date. Perhaps more surprising is that, unlike other complex disorders, recent advances in sequencing technology have only rarely been exploited in ADHD to identify rare variants that evade detection by traditional GWAS [<xref ref-type="bibr" rid="CR47">47</xref>].</p>
      <p>Motor delay, a consistent feature in <italic>Gnb5</italic> KO mouse, was also variably observed in patients we describe in this study. Similarly, hyperactivity, another prominent phenotype in <italic>Gnb5</italic> KO mouse, was only present at reduced penetrance in the patients we describe with <italic>GNB5</italic> mutation. This could be explained on the basis that these patients have partial whereas <italic>Gnb5</italic> KO mice have complete loss of function. Expectation is that the severity may correlate with severity of GÎ²5 disruption and other genetic factors may contribute to how much GÎ²5 destabilization the particular mutation would cause, e.g. strength of folding machinery, or lower tone of dopamine signaling in general in unaffected subjects. This suggests that even in this Mendelian form of ADHD, modifiers may play an important role in defining the final phenotype.</p>
      <p>Our previously published detailed analysis of the signaling perturbation in the brains of <italic>Gnb5</italic> KO mice suggested a model where increased availability of dopamine is not accompanied by a reciprocal increase in serotonin and that this imbalance may underlie the pathogenesis of hyperactivity in these mice [<xref ref-type="bibr" rid="CR28">28</xref>]. This model is further supported by our finding that psychostimulant drugs that increased the availability of dopamine failed to treat hyperactivity symptoms whereas drugs that increased the availability of serotonin resulted in a dramatic response [<xref ref-type="bibr" rid="CR28">28</xref>]. The implication of this on the choice of therapy of <italic>GNB5</italic>-related ADHD remains to be seen.</p>
      <p>G proteinâgated inwardly rectifying K+ (GIRK/Kir3) channels play an important role in synaptic plasticity and behavior [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. We have previously shown that GÎ²5 co-immunoprecipitates with the GIRK2 and GIRK3 neuronal subunits of GIRK and mediates the formation of GIRK-RGS complex [<xref ref-type="bibr" rid="CR29">29</xref>]. In hippocampal neurons from <italic>Gnb5</italic><sup>â/â</sup> mice, deactivation of GIRK signaling after GABA binding was significantly slower than in the wildtype counterpart. Furthermore, hippocampal CA1 pyramidal neurons from <italic>Gnb5</italic><sup>â/â</sup> mice showed altered evoked inhibitory postsynaptic currents, an important inhibitory signaling in the nervous system [<xref ref-type="bibr" rid="CR29">29</xref>]. These findings are likely relevant to the <italic>GNB5</italic>-related human phenotype because the use of the GABA agonist baclofen was found to induce marked reduction in hyperactivity in <italic>Gnb5</italic><sup>â/â</sup> mice [<xref ref-type="bibr" rid="CR29">29</xref>]. In addition, abnormal synaptic transmission in hippocampal neurons may contribute to the abnormality in expressive language we observe in all five patients with <italic>GNB5</italic> mutation given the role of hippocampal declarative memory system in language development [<xref ref-type="bibr" rid="CR50">50</xref>]. We also note that mutations in <italic>KCNJ6</italic>, which encode GIRK2, are known to cause a severe neurocognitive phenotype in humans [<xref ref-type="bibr" rid="CR51">51</xref>]. Finally, it is worth highlighting the role of GÎ²5 in regulating adenylate cyclase signaling in the striatum, a major player in motor coordination, as a potential mechanism to explain delayed fine motor coordination observed in patients with <italic>GNB5</italic> mutation [<xref ref-type="bibr" rid="CR52">52</xref>â<xref ref-type="bibr" rid="CR54">54</xref>]. Given the obligate nature of GÎ²5 association with members of the R7 RGS family and characteristic sensitization of GPCR signaling observed upon GÎ²5 elimination, we think that loss of the R7 RGS function underlies the majority of phenotypes in both humans and mice with disabled GÎ²5. Consistent with this idea, we report that S81L mutation in GÎ²5 detrimentally affects function of a representative member of the R7 RGS family, RGS9-2. Yet we expect that mutations in GÎ²5 would similarly affect all members of the R7 family, leading to a global reduction in RGS activity in multiple neuronal circuits across the brain. We should note, however, that at present we cannot rule out the RGS-independent effects associated with the GÎ²5 dysfunction, which may be interesting to re-visit if and when additional molecular reactions involving GÎ²5 are discovered.</p>
    </sec>
    <sec id="Sec15" sec-type="conclusion">
      <title>Conclusions</title>
      <p>In conclusion, we suggest that <italic>GNB5</italic> mutation in human results in an autosomal recessive neuropsychiatric disorder that is characterized by severe language delay, fine motor delay, and incompletely penetrant ADHD phenotype. It will be of interest to examine the contribution of rare variants in <italic>GNB5</italic> in future exome/genome sequencing studies of patients with ADHD, especially those with severe speech delay that is out of proportion to their IQ.</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec16">
          <title>Additional file</title>
          <p>
            <media position="anchor" xlink:href="13059_2016_1061_MOESM1_ESM.docx" id="MOESM1">
              <label>Additional file 1: Table S1.</label>
              <caption>
                <p>Clinical summary of the study patients. Clinical characteristics of the five patients included in this study with homozygous <italic>GNB5</italic> mutation. (DOCX 14 kb)</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank the family members for their enthusiastic participation. We thank Mr. Nickolas K. Skamangas for technical support.</p>
      <sec id="FPar1">
        <title>Funding</title>
        <p>This study was supported in part by KACST grant 13-BIO1113-20 (FSA) and National Institutes of Health grants DA026405 and MH105482 (KAM).</p>
      </sec>
      <sec id="FPar2">
        <title>Availability of data and materials</title>
        <p>The following accession number has been assigned by ClinVar: RCV000239906.</p>
      </sec>
      <sec id="FPar3">
        <title>Authorsâ contributions</title>
        <p>HES, IM, KAM, and FSA collected and analyzed data and wrote the manuscript. AA, SY, DNP, and NI collected and analyzed data. All authors read and approved the final manuscript.</p>
      </sec>
      <sec id="FPar4">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec id="FPar5">
        <title>Ethics approval and consent to participate</title>
        <p>This study is part of an IRB-approved research protocol (KFSHRC RAC#2121053). All participants provided written informed consent to participate in the study and for publication of their personal information and the findings of the study. All experimental methods comply with the Declaration of Helsinki.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parikshak</surname>
              <given-names>NN</given-names>
            </name>
            <name>
              <surname>Gandal</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Geschwind</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders</article-title>
          <source>Nat Rev Genet</source>
          <year>2015</year>
          <volume>16</volume>
          <fpage>441</fpage>
          <lpage>458</lpage>
          <pub-id pub-id-type="doi">10.1038/nrg3934</pub-id>
          <?supplied-pmid 26149713?>
          <pub-id pub-id-type="pmid">26149713</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Solovieff</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Cotsapas</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Purcell</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Smoller</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Pleiotropy in complex traits: challenges and strategies</article-title>
          <source>Nat Rev Genet</source>
          <year>2013</year>
          <volume>14</volume>
          <fpage>483</fpage>
          <lpage>495</lpage>
          <pub-id pub-id-type="doi">10.1038/nrg3461</pub-id>
          <?supplied-pmid 23752797?>
          <pub-id pub-id-type="pmid">23752797</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Catapano</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Manji</surname>
              <given-names>HK</given-names>
            </name>
          </person-group>
          <article-title>G protein-coupled receptors in major psychiatric disorders</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2007</year>
          <volume>1768</volume>
          <fpage>976</fpage>
          <lpage>993</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbamem.2006.09.025</pub-id>
          <?supplied-pmid 17078926?>
          <pub-id pub-id-type="pmid">17078926</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Urs</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Nicholls</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Caron</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>Integrated approaches to understanding antipsychotic drug action at GPCRs</article-title>
          <source>Curr Opin Cell Biol</source>
          <year>2014</year>
          <volume>27</volume>
          <fpage>56</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ceb.2013.11.002</pub-id>
          <?supplied-pmid 24680431?>
          <pub-id pub-id-type="pmid">24680431</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meye</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ramakers</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Adan</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The vital role of constitutive GPCR activity in the mesolimbic dopamine system</article-title>
          <source>Transl Psychiatry</source>
          <year>2014</year>
          <volume>4</volume>
          <fpage>e361</fpage>
          <pub-id pub-id-type="doi">10.1038/tp.2013.130</pub-id>
          <?supplied-pmid 24518399?>
          <pub-id pub-id-type="pmid">24518399</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gilman</surname>
              <given-names>AG</given-names>
            </name>
          </person-group>
          <article-title>G proteins: transducers of receptor-generated signals</article-title>
          <source>Annu Rev Biochem</source>
          <year>1987</year>
          <volume>56</volume>
          <fpage>615</fpage>
          <lpage>649</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.bi.56.070187.003151</pub-id>
          <?supplied-pmid 3113327?>
          <pub-id pub-id-type="pmid">3113327</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hollinger</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hepler</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Cellular regulation of RGS proteins: modulators and integrators of G protein signaling</article-title>
          <source>Pharmacol Rev</source>
          <year>2002</year>
          <volume>54</volume>
          <fpage>527</fpage>
          <lpage>559</lpage>
          <pub-id pub-id-type="doi">10.1124/pr.54.3.527</pub-id>
          <?supplied-pmid 12223533?>
          <pub-id pub-id-type="pmid">12223533</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ross</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Wilkie</surname>
              <given-names>TM</given-names>
            </name>
          </person-group>
          <article-title>GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins</article-title>
          <source>Annu Rev Biochem</source>
          <year>2000</year>
          <volume>69</volume>
          <fpage>795</fpage>
          <lpage>827</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.biochem.69.1.795</pub-id>
          <?supplied-pmid 10966476?>
          <pub-id pub-id-type="pmid">10966476</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Siderovski</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Hessel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mak</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Tyers</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>A new family of regulators of G-protein-coupled receptors?</article-title>
          <source>Curr Biol</source>
          <year>1996</year>
          <volume>6</volume>
          <fpage>211</fpage>
          <lpage>212</lpage>
          <pub-id pub-id-type="doi">10.1016/S0960-9822(02)00454-2</pub-id>
          <?supplied-pmid 8673468?>
          <pub-id pub-id-type="pmid">8673468</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dohlman</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Thorner</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>RGS proteins and signaling by heterotrimeric G proteins</article-title>
          <source>J Biol Chem</source>
          <year>1997</year>
          <volume>272</volume>
          <fpage>3871</fpage>
          <lpage>3874</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.272.7.3871</pub-id>
          <?supplied-pmid 9064301?>
          <pub-id pub-id-type="pmid">9064301</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berman</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Gilman</surname>
              <given-names>AG</given-names>
            </name>
          </person-group>
          <article-title>Mammalian RGS proteins: barbarians at the gate</article-title>
          <source>J Biol Chem</source>
          <year>1998</year>
          <volume>273</volume>
          <fpage>1269</fpage>
          <lpage>1272</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.273.3.1269</pub-id>
          <?supplied-pmid 9430654?>
          <pub-id pub-id-type="pmid">9430654</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burns</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Wensel</surname>
              <given-names>TG</given-names>
            </name>
          </person-group>
          <article-title>From molecules to behavior: New clues for RGS function in the striatum</article-title>
          <source>Neuron</source>
          <year>2003</year>
          <volume>38</volume>
          <fpage>853</fpage>
          <lpage>856</lpage>
          <pub-id pub-id-type="doi">10.1016/S0896-6273(03)00361-1</pub-id>
          <?supplied-pmid 12818171?>
          <pub-id pub-id-type="pmid">12818171</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishiguchi</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Sandberg</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Kooijman</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Martemyanov</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Pott</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Hagstrom</surname>
              <given-names>SA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Defects in RGS9 or its anchor protein R9AP in patients with slow photoreceptor deactivation</article-title>
          <source>Nature</source>
          <year>2004</year>
          <volume>427</volume>
          <fpage>75</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="doi">10.1038/nature02170</pub-id>
          <?supplied-pmid 14702087?>
          <pub-id pub-id-type="pmid">14702087</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Terzi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Stergiou</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Zachariou</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Regulators of G protein signaling in neuropsychiatric disorders</article-title>
          <source>Prog Mol Biol Transl Sci</source>
          <year>2009</year>
          <volume>86</volume>
          <fpage>299</fpage>
          <lpage>333</lpage>
          <pub-id pub-id-type="doi">10.1016/S1877-1173(09)86010-9</pub-id>
          <?supplied-pmid 20374720?>
          <pub-id pub-id-type="pmid">20374720</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cabrera</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>de Freitas</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Satpaev</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Slepak</surname>
              <given-names>VZ</given-names>
            </name>
          </person-group>
          <article-title>Identification of the GÎ²5-RGS7 protein complex in the retina</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>1998</year>
          <volume>249</volume>
          <fpage>898</fpage>
          <lpage>902</lpage>
          <pub-id pub-id-type="doi">10.1006/bbrc.1998.9218</pub-id>
          <?supplied-pmid 9731233?>
          <pub-id pub-id-type="pmid">9731233</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Makino</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Handy</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Arshavsky</surname>
              <given-names>VY</given-names>
            </name>
          </person-group>
          <article-title>The GTPase activating factor for transducin in rod photoreceptors is the complex between RGS9 and type 5Â G protein Î² subunit</article-title>
          <source>Proc Natl Acad Sci</source>
          <year>1999</year>
          <volume>96</volume>
          <fpage>1947</fpage>
          <lpage>1952</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.96.5.1947</pub-id>
          <?supplied-pmid 10051575?>
          <pub-id pub-id-type="pmid">10051575</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sondek</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Siderovski</surname>
              <given-names>DP</given-names>
            </name>
          </person-group>
          <article-title>GÎ³-like (GGL) domains: new frontiers in G-protein signaling and Î²-propeller scaffolding</article-title>
          <source>Biochem Pharmacol</source>
          <year>2001</year>
          <volume>61</volume>
          <fpage>1329</fpage>
          <lpage>1337</lpage>
          <pub-id pub-id-type="doi">10.1016/S0006-2952(01)00633-5</pub-id>
          <?supplied-pmid 11331068?>
          <pub-id pub-id-type="pmid">11331068</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Watson</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Aragay</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Slepak</surname>
              <given-names>VZ</given-names>
            </name>
            <name>
              <surname>Simon</surname>
              <given-names>MI</given-names>
            </name>
          </person-group>
          <article-title>A novel form of the G protein Î² subunit GÎ²5 is specifically expressed in the vertebrate retina</article-title>
          <source>J Biol Chem</source>
          <year>1996</year>
          <volume>271</volume>
          <fpage>28154</fpage>
          <lpage>28160</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.271.45.28154</pub-id>
          <?supplied-pmid 8910430?>
          <pub-id pub-id-type="pmid">8910430</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>He</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>El-Hodiri</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>C-K</given-names>
            </name>
            <name>
              <surname>Slep</surname>
              <given-names>KC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Modules in the photoreceptor RGS9-1âÂ·âGÎ² 5Â L GTPase-accelerating protein complex control effector coupling, GTPase acceleration, protein folding, and stability</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>37093</fpage>
          <lpage>37100</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M006982200</pub-id>
          <?supplied-pmid 10978345?>
          <pub-id pub-id-type="pmid">10978345</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Witherow</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Levay</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Cabrera</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Willars</surname>
              <given-names>GB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Complexes of the G protein subunit GÎ²5 with the regulators of G protein signaling RGS7 and RGS9 Characterization in native tissues and in transfected cells</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>24872</fpage>
          <lpage>24880</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M001535200</pub-id>
          <?supplied-pmid 10840031?>
          <pub-id pub-id-type="pmid">10840031</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kovoor</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>C-K</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Wensel</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Simon</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Lester</surname>
              <given-names>HA</given-names>
            </name>
          </person-group>
          <article-title>Co-expression of GÎ²5 enhances the function of two GÎ³ subunit-like domain-containing regulators of G protein signaling proteins</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>3397</fpage>
          <lpage>3402</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.275.5.3397</pub-id>
          <?supplied-pmid 10652332?>
          <pub-id pub-id-type="pmid">10652332</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Masuho</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Martemyanov</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>Macromolecular composition dictates receptor and G protein selectivity of regulator of G protein signaling (RGS) 7 and 9-2 protein complexes in living cells</article-title>
          <source>J Biol Chem</source>
          <year>2013</year>
          <volume>288</volume>
          <fpage>25129</fpage>
          <lpage>25142</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M113.462283</pub-id>
          <?supplied-pmid 23857581?>
          <pub-id pub-id-type="pmid">23857581</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keren-Raifman</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bera</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Zveig</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Peleg</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Witherow</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Slepak</surname>
              <given-names>VZ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Expression levels of RGS7 and RGS4 proteins determine the mode of regulation of the G proteinâactivated K+ channel and control regulation of RGS7 by GÎ²5</article-title>
          <source>FEBS Lett</source>
          <year>2001</year>
          <volume>492</volume>
          <fpage>20</fpage>
          <lpage>28</lpage>
          <pub-id pub-id-type="doi">10.1016/S0014-5793(01)02220-7</pub-id>
          <?supplied-pmid 11248230?>
          <pub-id pub-id-type="pmid">11248230</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Masuho</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Wakasugi-Masuho</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Posokhova</surname>
              <given-names>EN</given-names>
            </name>
            <name>
              <surname>Patton</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Martemyanov</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>Type 5Â G protein Î² subunit (GÎ²5) controls the interaction of regulator of G protein signaling 9 (RGS9) with membrane anchors</article-title>
          <source>J Biol Chem</source>
          <year>2011</year>
          <volume>286</volume>
          <fpage>21806</fpage>
          <lpage>21813</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M111.241513</pub-id>
          <?supplied-pmid 21511947?>
          <pub-id pub-id-type="pmid">21511947</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Watson</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Katz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Simon</surname>
              <given-names>MI</given-names>
            </name>
          </person-group>
          <article-title>A fifth member of the mammalian G-protein beta-subunit family. Expression in brain and activation of the beta 2 isotype of phospholipase C</article-title>
          <source>J Biol Chem</source>
          <year>1994</year>
          <volume>269</volume>
          <fpage>22150</fpage>
          <lpage>22156</lpage>
          <?supplied-pmid 8071339?>
          <pub-id pub-id-type="pmid">8071339</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Levay</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chanturiya</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Dvoriantchikova</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Bianco</surname>
              <given-names>SD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Targeted deletion of one or two copies of the G protein Î² subunit GÎ²5 gene has distinct effects on body weight and behavior in mice</article-title>
          <source>FASEB J</source>
          <year>2011</year>
          <volume>25</volume>
          <fpage>3949</fpage>
          <lpage>3957</lpage>
          <pub-id pub-id-type="doi">10.1096/fj.11-190157</pub-id>
          <?supplied-pmid 21804131?>
          <pub-id pub-id-type="pmid">21804131</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Pandey</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Seigneur</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Panicker</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Koo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>OM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Knockout of G protein Î²5 impairs brain development and causes multiple neurologic abnormalities in mice</article-title>
          <source>J Neurochem</source>
          <year>2011</year>
          <volume>119</volume>
          <fpage>544</fpage>
          <lpage>554</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1471-4159.2011.07457.x</pub-id>
          <?supplied-pmid 21883221?>
          <pub-id pub-id-type="pmid">21883221</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xie</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ge</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>VE</given-names>
            </name>
            <name>
              <surname>Haynes</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Renner</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Meisel</surname>
              <given-names>RL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>GÎ²5-RGS complexes are gatekeepers of hyperactivity involved in control of multiple neurotransmitter systems</article-title>
          <source>Psychopharmacol (Berl)</source>
          <year>2012</year>
          <volume>219</volume>
          <fpage>823</fpage>
          <lpage>834</lpage>
          <pub-id pub-id-type="doi">10.1007/s00213-011-2409-y</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xie</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Kourrich</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>ColÃ³n-Saez</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Wickman</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>G [beta] 5 recruits R7 RGS proteins to GIRK channels to regulate the timing of neuronal inhibitory signaling</article-title>
          <source>Nat Neurosci</source>
          <year>2010</year>
          <volume>13</volume>
          <fpage>661</fpage>
          <lpage>663</lpage>
          <pub-id pub-id-type="doi">10.1038/nn.2549</pub-id>
          <?supplied-pmid 20453851?>
          <pub-id pub-id-type="pmid">20453851</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alkuraya</surname>
              <given-names>FS</given-names>
            </name>
          </person-group>
          <article-title>Genetics and genomic medicine in Saudi Arabia</article-title>
          <source>Mol Genet Genomic Med</source>
          <year>2014</year>
          <volume>2</volume>
          <fpage>369</fpage>
          <lpage>378</lpage>
          <pub-id pub-id-type="doi">10.1002/mgg3.97</pub-id>
          <?supplied-pmid 25333061?>
          <pub-id pub-id-type="pmid">25333061</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alsalem</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Halees</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Anazi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Alshamekh</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Alkuraya</surname>
              <given-names>FS</given-names>
            </name>
          </person-group>
          <article-title>Autozygome sequencing expands the horizon of human knockout research and provides novel insights into human phenotypic variation</article-title>
          <source>PLoS Genet</source>
          <year>2013</year>
          <volume>9</volume>
          <fpage>e1004030</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.1004030</pub-id>
          <?supplied-pmid 24367280?>
          <pub-id pub-id-type="pmid">24367280</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alazami</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Shamseldin</surname>
              <given-names>HE</given-names>
            </name>
            <name>
              <surname>Anazi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Al-Dosari</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Alzahrani</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Accelerating novel candidate gene discovery in neurogenetic disorders via whole-exome sequencing of prescreened multiplex consanguineous families</article-title>
          <source>Cell Rep</source>
          <year>2015</year>
          <volume>10</volume>
          <fpage>148</fpage>
          <lpage>161</lpage>
          <pub-id pub-id-type="doi">10.1016/j.celrep.2014.12.015</pub-id>
          <?supplied-pmid 25558065?>
          <pub-id pub-id-type="pmid">25558065</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nek</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Accelerating matchmaking of novel dysmorphology syndromes through clinical and genomic characterization of a large cohort</article-title>
          <source>Genet Med</source>
          <year>2016</year>
          <volume>18</volume>
          <fpage>686</fpage>
          <lpage>695</lpage>
          <pub-id pub-id-type="doi">10.1038/gim.2015.147</pub-id>
          <pub-id pub-id-type="pmid">26633546</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <mixed-citation publication-type="other">Alkuraya FS. Discovery of rare homozygous mutations from studies of consanguineous pedigrees. Curr Protoc Hum Genet. 2012;Chapter 6:Unit6.12.</mixed-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alkuraya</surname>
              <given-names>FS</given-names>
            </name>
          </person-group>
          <article-title>Homozygosity mapping: one more tool in the clinical geneticistâs toolbox</article-title>
          <source>Genet Med</source>
          <year>2010</year>
          <volume>12</volume>
          <fpage>236</fpage>
          <lpage>239</lpage>
          <pub-id pub-id-type="doi">10.1097/GIM.0b013e3181ceb95d</pub-id>
          <?supplied-pmid 20134328?>
          <pub-id pub-id-type="pmid">20134328</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alkuraya</surname>
              <given-names>FS</given-names>
            </name>
          </person-group>
          <article-title>The application of next-generation sequencing in the autozygosity mapping of human recessive diseases</article-title>
          <source>Hum Genet</source>
          <year>2013</year>
          <volume>132</volume>
          <fpage>1197</fpage>
          <lpage>1211</lpage>
          <pub-id pub-id-type="doi">10.1007/s00439-013-1344-x</pub-id>
          <?supplied-pmid 23907654?>
          <pub-id pub-id-type="pmid">23907654</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hollins</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kuravi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Digby</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Lambert</surname>
              <given-names>NA</given-names>
            </name>
          </person-group>
          <article-title>The c-terminus of GRK3 indicates rapid dissociation of G protein heterotrimers</article-title>
          <source>Cell Signal</source>
          <year>2009</year>
          <volume>21</volume>
          <fpage>1015</fpage>
          <lpage>1021</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cellsig.2009.02.017</pub-id>
          <?supplied-pmid 19258039?>
          <pub-id pub-id-type="pmid">19258039</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martemyanov</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Yoo</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Skiba</surname>
              <given-names>NP</given-names>
            </name>
            <name>
              <surname>Arshavsky</surname>
              <given-names>VY</given-names>
            </name>
          </person-group>
          <article-title>R7BP, a novel neuronal protein interacting with RGS proteins of the R7 family</article-title>
          <source>J Biol Chem</source>
          <year>2005</year>
          <volume>280</volume>
          <fpage>5133</fpage>
          <lpage>5136</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.C400596200</pub-id>
          <?supplied-pmid 15632198?>
          <pub-id pub-id-type="pmid">15632198</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <mixed-citation publication-type="other">Masuho I, Ostrovskaya O, Kramer GM, Jones CD, Xie K, Martemyanov KA. Distinct profiles of functional discrimination among G proteins determine the actions of G proteinâcoupled receptors. Sci Signal. 2015;8:ra123â3.</mixed-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheever</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Snyder</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Gershburg</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Siderovski</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Harden</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Sondek</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Crystal structure of the multifunctional Gbeta5-RGS9 complex</article-title>
          <source>Nat Struct Mol Biol</source>
          <year>2008</year>
          <volume>15</volume>
          <fpage>155</fpage>
          <lpage>162</lpage>
          <pub-id pub-id-type="doi">10.1038/nsmb.1377</pub-id>
          <?supplied-pmid 18204463?>
          <pub-id pub-id-type="pmid">18204463</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Worth</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Blundell</surname>
              <given-names>TL</given-names>
            </name>
          </person-group>
          <article-title>On the evolutionary conservation of hydrogen bonds made by buried polar amino acids: the hidden joists, braces and trusses of protein architecture</article-title>
          <source>BMC Evol Biol</source>
          <year>2010</year>
          <volume>10</volume>
          <fpage>1</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2148-10-161</pub-id>
          <pub-id pub-id-type="pmid">20044934</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eswar</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ramakrishnan</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Deterministic features of side-chain main-chain hydrogen bonds in globular protein structures</article-title>
          <source>Protein Eng</source>
          <year>2000</year>
          <volume>13</volume>
          <fpage>227</fpage>
          <lpage>238</lpage>
          <pub-id pub-id-type="doi">10.1093/protein/13.4.227</pub-id>
          <?supplied-pmid 10810153?>
          <pub-id pub-id-type="pmid">10810153</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Porter</surname>
              <given-names>MY</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Pozharski</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Koelle</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Martemyanov</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>A conserved protein interaction interface on the type 5Â G protein Î² subunit controls proteolytic stability and activity of R7 family regulator of G protein signaling proteins</article-title>
          <source>J Biol Chem</source>
          <year>2010</year>
          <volume>285</volume>
          <fpage>41100</fpage>
          <lpage>41112</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M110.163600</pub-id>
          <?supplied-pmid 20959458?>
          <pub-id pub-id-type="pmid">20959458</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>American Psychiatric Association</collab>
          </person-group>
          <source>Diagnostic and statistical manual of mental disorders (DSM-5Â®)</source>
          <year>2013</year>
          <publisher-loc>Arlington</publisher-loc>
          <publisher-name>American Psychiatric Association Publishing</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gizer</surname>
              <given-names>IR</given-names>
            </name>
            <name>
              <surname>Ficks</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Waldman</surname>
              <given-names>ID</given-names>
            </name>
          </person-group>
          <article-title>Candidate gene studies of ADHD: a meta-analytic review</article-title>
          <source>Hum Genet</source>
          <year>2009</year>
          <volume>126</volume>
          <fpage>51</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="doi">10.1007/s00439-009-0694-x</pub-id>
          <?supplied-pmid 19506906?>
          <pub-id pub-id-type="pmid">19506906</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Franke</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Neale</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Faraone</surname>
              <given-names>SV</given-names>
            </name>
          </person-group>
          <article-title>Genome-wide association studies in ADHD</article-title>
          <source>Hum Genet</source>
          <year>2009</year>
          <volume>126</volume>
          <fpage>13</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="doi">10.1007/s00439-009-0663-4</pub-id>
          <?supplied-pmid 19384554?>
          <pub-id pub-id-type="pmid">19384554</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Demontis</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lescai</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>BÃ¸rglum</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Glerup</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ãstergaard</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Mors</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Whole-exome sequencing reveals increased burden of rare functional and disruptive variants in candidate risk genes in individuals with persistent attention-deficit/hyperactivity disorder</article-title>
          <source>J Am Acad Child Adolesc Psychiatry</source>
          <year>2016</year>
          <volume>55</volume>
          <fpage>521</fpage>
          <lpage>523</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jaac.2016.03.009</pub-id>
          <?supplied-pmid 27238071?>
          <pub-id pub-id-type="pmid">27238071</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>LÃ¼scher</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jan</surname>
              <given-names>LY</given-names>
            </name>
            <name>
              <surname>Stoffel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Malenka</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Nicoll</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>G protein-coupled inwardly rectifying K+ channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons</article-title>
          <source>Neuron</source>
          <year>1997</year>
          <volume>19</volume>
          <fpage>687</fpage>
          <lpage>695</lpage>
          <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80381-5</pub-id>
          <?supplied-pmid 9331358?>
          <pub-id pub-id-type="pmid">9331358</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chung</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Ge</surname>
              <given-names>W-P</given-names>
            </name>
            <name>
              <surname>Qian</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Wiser</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Jan</surname>
              <given-names>YN</given-names>
            </name>
            <name>
              <surname>Jan</surname>
              <given-names>LY</given-names>
            </name>
          </person-group>
          <article-title>G protein-activated inwardly rectifying potassium channels mediate depotentiation of long-term potentiation</article-title>
          <source>Proc Natl Acad Sci</source>
          <year>2009</year>
          <volume>106</volume>
          <fpage>635</fpage>
          <lpage>640</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0811685106</pub-id>
          <?supplied-pmid 19118199?>
          <pub-id pub-id-type="pmid">19118199</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duff</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Brown-Schmidt</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>The hippocampus and the flexible use and processing of language</article-title>
          <source>Front Hum Neurosci</source>
          <year>2012</year>
          <volume>6</volume>
          <fpage>69</fpage>
          <pub-id pub-id-type="doi">10.3389/fnhum.2012.00069</pub-id>
          <?supplied-pmid 22493573?>
          <pub-id pub-id-type="pmid">22493573</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Masotti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Uva</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Davis-Keppen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Basel-Vanagaite</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pisaneschi</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Keppen-Lubinsky syndrome is caused by mutations in the inwardly rectifying K+ channel encoded by KCNJ6</article-title>
          <source>Am J Hum Genet</source>
          <year>2015</year>
          <volume>96</volume>
          <fpage>295</fpage>
          <lpage>300</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajhg.2014.12.011</pub-id>
          <?supplied-pmid 25620207?>
          <pub-id pub-id-type="pmid">25620207</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Graybiel</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>The basal ganglia</article-title>
          <source>Curr Biol</source>
          <year>2000</year>
          <volume>10</volume>
          <fpage>R509</fpage>
          <lpage>R511</lpage>
          <pub-id pub-id-type="doi">10.1016/S0960-9822(00)00593-5</pub-id>
          <?supplied-pmid 10899013?>
          <pub-id pub-id-type="pmid">10899013</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kreitzer</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Malenka</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Striatal plasticity and basal ganglia circuit function</article-title>
          <source>Neuron</source>
          <year>2008</year>
          <volume>60</volume>
          <fpage>543</fpage>
          <lpage>554</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuron.2008.11.005</pub-id>
          <?supplied-pmid 19038213?>
          <pub-id pub-id-type="pmid">19038213</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xie</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Masuho</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Brand</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dessauer</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Martemyanov</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>The complex of G protein regulator RGS9-2 and Gbeta(5) controls sensitization and signaling kinetics of type 5 adenylyl cyclase in the striatum</article-title>
          <source>Sci Signal</source>
          <year>2012</year>
          <volume>5</volume>
          <fpage>ra63</fpage>
          <pub-id pub-id-type="doi">10.1126/scisignal.2002922</pub-id>
          <?supplied-pmid 22932702?>
          <pub-id pub-id-type="pmid">22932702</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>